Surgery for li fraumeni syndrome: Pushing the limits of surgical oncology

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 38, Issue 1, 2015, Pages 98-102

  Langan, Russell C ^a,b   Lagisetty, Kiran H ^a,c   Atay, Scott ^a,c   Pandalai, Prakash ^a   Stojadinovic, Alexander ^d,e   Rudloff, Udo ^a   Avital, Itzhak ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Walter Reed National Military   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^f Virginia Health System   (United States)

Author keywords

Li Fraumeni syndrome; metastasectomy; simultaneous pancreaticoduodenectomy and hepatectomy

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; PROTEIN P53; TRANSCRIPTION FACTOR CDX2;

ABDOMINAL HYSTERECTOMY; ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHOLECYSTECTOMY; COMPUTER ASSISTED TOMOGRAPHY; FAMILIAL CANCER; FEMALE; GERMLINE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LIVER METASTASIS; MALIGNANT FIBROUS HISTIOCYTOMA; MIDDLE AGED; NEPHRECTOMY; PANCREATICODUODENECTOMY; PARTIAL HEPATECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; RADIOFREQUENCY ABLATION; REVIEW; SALPINGOOOPHORECTOMY; SPLENECTOMY; TUMOR SUPPRESSOR GENE; WEDGE RESECTION; ADENOCARCINOMA; ADRENAL CORTEX TUMOR; ADRENOCORTICAL CARCINOMA; BREAST NEOPLASMS; CARCINOMA, BASAL CELL; CARCINOMA, DUCTAL, BREAST; COMMON BILE DUCT NEOPLASMS; HISTIOCYTOMA, MALIGNANT FIBROUS; LI-FRAUMENI SYNDROME; LIVER NEOPLASMS; LIVER RESECTION; NEOPLASMS, MULTIPLE PRIMARY; PATHOLOGY; SECONDARY; SKIN NEOPLASMS; VATER PAPILLA;

ADENOCARCINOMA; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; AMPULLA OF VATER; BREAST NEOPLASMS; CARCINOMA, BASAL CELL; CARCINOMA, DUCTAL, BREAST; COMMON BILE DUCT NEOPLASMS; FEMALE; HEPATECTOMY; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; LI-FRAUMENI SYNDROME; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PANCREATICODUODENECTOMY; SKIN NEOPLASMS;

EID: 84922147073     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182880bc5     Document Type: Review

References (24)

1. Cady B. Basic principles in surgical oncology. Arch Surg. 1997;132:338-346.
2. Upton B, Chu Q, Li BD. Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms. Surg Oncol Clin N Am. 2009;18:145-156, ix.
3. Daly MB, Axilbund JE, Buys S, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010;8:562-594.
4. Chompret A, Abel A, Stoppa-Lyonnet D, et al. Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet. 2001;38:43-47.
5. Landry CS, Waguespack SG, Perrier ND. Surgical management of nonmultiple endocrine neoplasia endocrinopathies: state-of-the-Art review. Surg Clin North Am. 2009;89:1069-1089.
6. Ribeiro RC, Pinto EM, Zambetti GP. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies. Best Pract Res Clin Endocrinol Metab. 2010;24:477-490.
7. Ripley RT, Kemp CD, Davis JL, et al. Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol. 2011;18:1972-1979.
8. Fassnacht M, Terzolo M, Allolio B, et al. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med. 2012;366:2189-2197.
9. Singh A, Singh T, Chaudhary A. Synchronous resection of solitary liver metastases with pancreaticoduodenectomy. J Pancreas. 2010;11:434-438.
10. De Jong MC, Farnell MB, Sclabas G, et al. Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg. 2010;252:142-148.
11. McKay A, Sutherland FR, Bathe OF, et al. Morbidity and mortality following multivisceral resections in complex hepatic and pancreatic surgery. J Gastrointest Surg. 2008;12:86-90.
12. Nikfarjam M, Sehmbey M, Kimchi ET, et al. Additional organ resection combined with pancreaticoduodenectomy does not increase postoperative morbidity and mortality. J Gastrointest Surg. 2009;13:915-921.
13. Michalski CW, Erkan M, Hüser N, et al. Resection of primary pancreatic cancer and liver metastasis: a systematic review. Dig Surg. 2008;25:473-480.
14. Heymann S, Delaloge S, Rahal A, et al. Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol. 2010;5:104.
15. Hisada M, Garber JE, Fung CY, et al. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90:606-611.
16. Nutting C, Camplejohn RS, Gilchrist R, et al. A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy? Clin Oncol (R Coll Radiol). 2000;12:300-304.
17. Limacher JM, Frebourg T, Natarajan-Ame S, et al. Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome. Int J Cancer. 2001;96:238-242.
18. Salmon A, Amikam D, Sodha N, et al. Rapid development of postradiotherapy sarcoma and breast cancer in a patient with a novel germline'de-novo' TP53 mutation. Clin Oncol (R Coll Radiol). 2007;19:490-493.
19. Mitchel RE, Jackson JS, Carlisle SM. Upper dose thresholds for radiation-induced adaptive response against cancer in high-doseexposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res. 2004;162:20-30.
20. King P, Craft AW, Malcolm AJ. p53 expression in three separate tumours from a patient with Li-Fraumeni's syndrome. J Clin Pathol. 1993;46:676-677.
21. Vranic S, Kapur L, Foco F, et al. The first case of Li-Fraumeni syndrome in Bosnia and Herzegovina: case report. Pathologica. 2006;98:156-159.
22. Izawa N, Matsumoto S, Manabe J, et al. A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene. Int J Clin Oncol. 2008;13:78-82.
23. Landolsi S, Gharbi O, Zrig M, et al. Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation. Ann Biol Clin (Paris). 2010;68:346-350.
24. Curiel-Lewandrowski C, Speetzen LS, Cranmer L, et al. Multiple primary cutaneous melanomas in Li-Fraumeni syndrome. Arch Dermatol. 2011;147:248-250.